Canton Strategic Holdings (CNTN) Non-Current Debt (2020 - 2025)

Canton Strategic Holdings (CNTN) posted Non-Current Debt of $161117.0 for Q3 2025, down 35.48% on a QoQ basis from $249716.0 in Q2 2025.

Canton Strategic Holdings (CNTN) Non-Current Debt (2020 - 2025) Analysis & Trends

Canton Strategic Holdings' Non-Current Debt history runs 2 years deep, the most recent figure standing at $161117.0 for Q3 2025.

Quarterly Non-Current Debt changed N/A year-over-year to $161117.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $161117.0 (changed N/A YoY) and the FY2020 annual result came in at $201737.0, changed N/A from the prior year.
Non-Current Debt was $161117.0 for Q3 2025 at Canton Strategic Holdings, down from $249716.0 in the prior quarter.
Across five years, Non-Current Debt topped out at $271454.0 in Q1 2025 and bottomed at $161117.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	105.94 Mn
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	842.92 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	1.99 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Canton Strategic Holdings	427.87 Mn	427.87 Mn	-	-

Download Data